Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
Detailed Information | |
---|---|
ID | 1224 |
Name of the vaccine | DVC-LVS |
Microbe | Bacteria |
Disease name | Tularemia (Rabbit fever) |
Name of bacteria | Francisella tularensis |
Type of vaccine | Live attenuated |
Nucleic acid content | Circular DNA |
Age | 18 to 45 years |
Description of the vaccine | Tularemia vaccine manufactured by DynPort vaccine company. |
Name of the manufacturer | National Institute of Allergy and Infectious Diseases (NIAID) |
Name of the manufacturing country | United States |
Year of manufacture | 2012 |
Clinical Phase status | Clinical - Phase 2 |
Bacterial strain | Gram-negative bacteria. |
Efficacy | NA |
Vaccine formulation | NA |
Dosage | Single dose. |
Mechanism of action | NA |
Route of administration | Scarification |
Indications | NA |
Export | NA |
Approval | NA |
Adjuvant | NA |
Repurposing | NA |
Side effects of vaccine | NA |
Post vaccination | NA |
Dose type | Single dose |
Interspecies transfer | Yes (through the bite of infected insects) |
PubMed identifier | NA |
Clinical trial number | NCT01150695 |
Reference | NA |
Other name | NA |
Additional Links | NA |